We invest in emerging, high-growth companies with a competitive advantage, experienced management, proprietary technology, and the ability to create long-term value for investors.
We invest primarily in companies involved in Biotech & Life Sciences, Nanotechnology, Computer-related Technology, and Medical Devices & Technologies.
